A novel prognostic indicator known as the platelet-neutrophil-monocyte-lymphocyte ratio (PNMLR) has recently emerged from a comprehensive study evaluating survival outcomes...

In a groundbreaking development in the treatment of rare hematologic malignancies, researchers have unveiled promising results for a novel antibody-drug...

In a groundbreaking advance poised to reshape the landscape of cancer immunotherapy, researchers have uncovered compelling evidence that specific antioxidants...

A groundbreaking study conducted by researchers at Fox Chase Cancer Center, unveiled at the prestigious American Society of Clinical Oncology’s...

In a groundbreaking advancement that could redefine therapeutic strategies against ovarian cancer, researchers have unveiled that the regulator of G-protein...

A groundbreaking study emerging from the prestigious UCLA Health Jonsson Comprehensive Cancer Center has unveiled compelling evidence that the immunotherapy...

In a groundbreaking development that promises to redefine prognostic evaluation in pediatric oncology, researchers have unveiled the pan-immune-inflammation value (PIV)...

In a groundbreaking study published in BMC Cancer, researchers have unveiled the remarkable efficacy of targeting the oncogenic regulator mdm2...

A recent groundbreaking study published in JAMA has evaluated the efficacy of a novel blood-based screening test designed for the...

In a groundbreaking study that could reshape the understanding and treatment of aggressive prostate cancer, researchers at the University of...